MOH Ad Compliance Checker.

Why Singapore clinic advertising rules are stricter than they look

Singapore regulates healthcare advertising under the Healthcare Services (Advertisement) Regulations 2021, made under the Healthcare Services Act (HCSA), alongside the Health Sciences Authority's (HSA) separate controls on advertising health products under the Health Products Act. Together they ban patient testimonials and reviews in advertising by default, before/after imagery outright, guarantees and absolute-outcome claims, comparisons with other providers, promotional pricing language ("from $", percentage discounts, limited-time offers), gifts and lucky draws tied to booking a service, and public advertising of named prescription-only medicines and professional-use-only devices — including specifically naming botulinum toxin (Botox) or dermal fillers.

This self-check walks your actual ad copy through the risk areas that most often trip up clinic advertising in Singapore, flags the specific phrase (or the specific missing element) that triggered each one, explains which rule it touches, and suggests a compliant rewrite. It's the same discipline our Singapore team applies when building campaigns for regulated clinic accounts — see our MOH-compliant aesthetic clinic playbook for the full strategy layer, or our guide to choosing a Singapore marketing agency if you're evaluating who runs this for you. Wondering specifically about before/after photos? See our dedicated guide on that one rule. Following up leads by WhatsApp or SMS afterward? That's a separate compliance layer — check it with our PDPA & DNC checker.

What this checker looks for

Nine rule categories, drawn from the sources cited below — each one covers a specific pattern our checker scans your pasted text for:

• Patient testimonials & reviews — Under Regulation 14 of the Healthcare Services (Advertisement) Regulations 2021, patient testimonials and reviews are not allowed in advertising by default. The narrow exception is genuine, direct, unpaid, unedited reviews appearing only on your own premises, website or own social media — never paid reviews, influencer endorsements, solicited testimonials, or reproduced/screenshotted patient posts used as promotional material. Source
• Laudatory / superlative language — Regulation 5 bans laudatory or superlative terms in healthcare advertising even when truthful — the rule is about the promotional framing itself, not whether the claim is provable. HSA/MOH's own guidance on non-promotional information separately confirms this: educational materials must not use 'promotional or laudatory terms e.g. "get it now", "at a discounted rate", "fastest", "best", "safest"' to induce demand. Source
• Before/after imagery — Before/after photos or videos are prohibited in healthcare advertising under Regulation 5 — a disclaimer does not make them compliant. The one exception is a doctor showing such images privately during an actual patient consultation, which is not advertising. Source
• Guarantees & absolute claims — Regulation 5 prohibits guarantees, fixed-outcome promises and absolute claims ("guaranteed", "100% effective", "permanent", "miracle", "instant") because they solicit consumption of a clinical decision that depends on individual assessment — the same underlying principle HSA's guidance states for health products: advertising must not mislead or create unrealistic expectations. Source
• Comparative or disparaging claims — Regulation 5 prohibits comparing your quality of service against competitors or disparaging other providers — this applies even when a competitor isn't named, if the ad implies comparative superiority over "other clinics" generally. Source
• Medical certificate (MC) promotion — Advertising the potential to obtain a medical certificate through a service — phrases like "MC in minutes" or framing sick leave as a guaranteed, fast outcome of teleconsultation — is prohibited under Regulation 5. An MC reflects a doctor's clinical assessment, not a service feature to market. Source
• Promotional pricing language — Regulation 5 requires exact, final prices — a healthcare ad may not use "from", "as low as", crossed-out usual prices, percentage discounts, or time-limited/"validity period" pricing language. Payment plans are allowed but must only be disclosed at the point of payment, not advertised as a promotional hook. Source
• Gifts, vouchers & lucky draws — Regulation 15 prohibits advertising any gift, freebie, lucky draw or voucher tied to purchasing a healthcare service — any benefit designed to solicit consumption of the service is restricted. Referral reward programs specifically may not be advertised either; patients may only learn about them at the point of payment. Source
• Prescription-only medicines & professional-use devices — HSA/MOH's guidance confirms Prescription-Only Medicines (POM) and Professional-Use-Only medical devices — which explicitly includes botulinum toxin (Botox) and hyaluronic acid dermal fillers as named examples — are not allowed to be advertised to the public at all, because their use depends on a doctor's clinical judgement and informed discussion with the patient, not a marketing-driven choice. Source

Methodology — where this checklist comes from

Rules marked "verified" in our sourcing were fetched directly from official government pages/PDFs (HSA/MOH's guidance on advertisement controls, dnc.gov.sg) and read in full this session. Rules citing specific regulation numbers (5, 13, 14, 15 of the Healthcare Services (Advertisement) Regulations 2021) are sourced via a specialist Singapore healthcare-marketing compliance guide, because the primary legislation portal (sso.agc.gov.sg) blocked automated access when this tool was built — logged here rather than silently worked around. It is not a substitute for legal advice: treat a “no flags” result as a reasonable first pass, not clearance. Running a Malaysian clinic instead? Use our KKM ad checker.

Rules current as of: July 2026

PHMC advertising regulations: what replaced them

Before Singapore's Healthcare Services Act (HCSA) came into force, clinic advertising sat under the Private Hospitals and Medical Clinics Act (PHMC) and its subsidiary PHMC advertising regulations — the “Private Hospitals and Medical Clinics (Publicity) Regulations”. If you're reading older guidance that cites PHMC advertising regulations, that regime has been replaced. Singapore clinic advertising is now governed by the Healthcare Services (Advertisement) Regulations made under HCSA, and this checker tests your ad copy against that current HCSA regime, not against the retired PHMC advertising regulations.

The transition from PHMC to HCSA rolled out in phases from 2022 onward and licensable healthcare services have been migrating from PHMC licensing to HCSA licensing on a service-class basis. For clinic advertising specifically, what carried over from the PHMC advertising regulations into the HCSA regime is the substance: patient testimonials in advertising are still restricted, before/after imagery is still prohibited, guarantees and comparative claims are still barred, promotional pricing and gift/lucky-draw incentives tied to clinical services are still not allowed, and named prescription-only medicines still cannot be advertised to the public. A licensee reading old PHMC advertising regulations guidance will find the direction of travel intact — what changed is the legal instrument, the wording, and the enforcement authority. Confirm the current HCSA subsidiary-regulation citation against MOH/HCSA's own published guidance before quoting a specific regulation number; the exact successor mapping from the 2019 PHMC (Publicity) Regulations to the HCSA subsidiary instrument is a named gap in our sourcing notes and stays a gap until reviewed.

The practical answer for a clinic operator: assume the substance you learned under the PHMC advertising regulations still applies, but read the current text under HCSA before publishing. Paste your ad copy into the checker above and it will flag against the current HCSA rule set; for the underlying source list and where each rule is drawn from, see our Singapore healthcare advertising rules reference.